 2. Subjects with malignancies or a history of malignancies with the exception of basal cell carcinoma BCC of the skin will be excluded from the study. Those subjects with a history of BCC are eligible for enrollment, and will be monitored by a qualified dermatologist every 8 weeks for a period of 6 months for evaluation of their skin condition. Subjects with existing BCC will be excluded from the study. 